Amir Nobakht, M.D.

Amir is the former COO and Head of Commercialization at CarthroniX Inc., where Dr. Nobakht led new drug development in osteoarthritis, fibrosis and oncology and was responsible for bringing new technologies from labs to investigational new drug applications as well as designing and implementing clinical trials, He holds and M.D. and M.B.A from the University of Southern California, and B.A. in Molecular Biology and Philosophy, Politics and Economics from Claremont McKenna College. Dr. Nobakht holds 2 US patents.